University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Grey Faricimab®
NICE TA 1004 Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion
Status: Green Febuxostat tablets
Status: Red Fedratinib (Inrebic®)
Status: Red Fenfluramine
Status: Amber Ferric maltol (Feraccru®)

For the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD), unable to tolerate other oral iron formulations.

Supported by a RICaD

Status: Red Filgotinib (Jyseleca®)
Status: Red Filgotinib (Jyseleca®)#1.5
Status: Green Finerenone (Kerendia®)

Prescribing to be in line with the prescribing support document.

Status: Red Fingolimod capsules
Status: Red Flourescein sodium 10% injection (10 x 5ml amps)
Building healthier lives
Back to top